Insider Transactions in Q4 2023 at Better Therapeutics, Inc. (BTTX)
Insider Transaction List (Q4 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 18
2023
|
David P Perry Executive Chairman |
BUY
Grant, award, or other acquisition
|
Direct |
3,750
+3.44%
|
-
|
|
Dec 18
2023
|
Leslie A. Miller Principal Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
3,587
+16.67%
|
-
|
|
Dec 18
2023
|
Andrew J. Armanino |
BUY
Grant, award, or other acquisition
|
Direct |
3,750
+18.0%
|
-
|
|
Dec 18
2023
|
Geoffrey M. Parker |
BUY
Grant, award, or other acquisition
|
Direct |
3,750
+0.36%
|
-
|
|
Dec 18
2023
|
Kristin Wynholds Chief Product Officer |
BUY
Grant, award, or other acquisition
|
Direct |
25,362
+10.1%
|
-
|
|
Dec 18
2023
|
Risa J Lavizzo Mourey |
BUY
Grant, award, or other acquisition
|
Direct |
3,750
+21.43%
|
-
|
|
Dec 18
2023
|
Richard H Carmona |
BUY
Grant, award, or other acquisition
|
Direct |
3,750
+2.33%
|
-
|
|
Dec 18
2023
|
Elder Granger |
BUY
Grant, award, or other acquisition
|
Direct |
3,750
+8.65%
|
-
|
|
Dec 18
2023
|
Mark A. Berman Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
25,362
+5.36%
|
-
|
|
Dec 18
2023
|
Frank Karbe Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
62,500
+10.61%
|
-
|